These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6055527)

  • 1. Contrasting locomotor effects of catecholamine releasers and tyrosine hydroxylase inhibitors in MAO-inhibited mice.
    Weissman A; Koe BK
    Psychopharmacologia; 1967 Aug; 11(3):282-6. PubMed ID: 6055527
    [No Abstract]   [Full Text] [Related]  

  • 2. Adrenal and brain catecholamine responses to acute and chronic morphine administration to rats, after inhibition of tyrosine hydroxylase and monoamine oxidase.
    Guaza C; Torrellas A; Borrell J; Borrell S
    Arch Farmacol Toxicol; 1983 Aug; 9(2):131-40. PubMed ID: 6140899
    [No Abstract]   [Full Text] [Related]  

  • 3. The degeneration contraction of a sympathetically innervated smooth muscle in the rat after reserpine, inhibition of monoamine oxidase or tyrosine hydroxylase.
    Lundberg D
    Acta Physiol Scand; 1970 Sep; 80(1):107-16. PubMed ID: 4394456
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of tetrabenazine on methamphetamine-induced hyperactivity in mice are dependent on order and time-course of administration.
    Kuribara H
    Pharmacol Biochem Behav; 1997 Jan; 56(1):9-14. PubMed ID: 8981603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intraventricular dopamine on the spontaneous locomotor activity of rats pretreated with nialamide, reserpine, or alpha-methyl-p-tyrosine.
    Malec D; Kleinrok Z
    Pol J Pharmacol Pharm; 1973; 25(4):357-66. PubMed ID: 4774244
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of disulfiram and diethyldithiocarbamate on spontaneous locomotor activity and brain catecholamine levels in mice.
    Moore KE
    Biochem Pharmacol; 1969 Jul; 18(7):1627-34. PubMed ID: 5806105
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of alpha-methyltyrosine on stress-induced changes in seizure susceptibility.
    Goldberg ME; Salama AI
    Eur J Pharmacol; 1970 Feb; 9(2):175-82. PubMed ID: 5437153
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute effects of alpha-methyltyrosine on brain catecholamine levels and on spontaneous and amphetamine-stimulated motor activity in mice.
    Dominic JA; Moore KE
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):166-76. PubMed ID: 5353469
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of dopamine in motor excitation of mice induced by brain catecholamine releasers.
    Graeff FG
    J Pharm Pharmacol; 1966 Sep; 18(9):627-8. PubMed ID: 4381952
    [No Abstract]   [Full Text] [Related]  

  • 11. 2-Phenylethylamine as a possible mediator for delta9-tetrahydrocannabinol-induced stimulation.
    Sabelli HC; Vazquez AJ; Mosnaim AD; Madrid-Pedemonte L
    Nature; 1974 Mar; 248(5444):144-5. PubMed ID: 4274244
    [No Abstract]   [Full Text] [Related]  

  • 12. Antagonism by monoamine oxidase inhibitors of alpha-methyltyrosine-induced catecholamine depletion and behavioral depression.
    Moore KE; Rech RH
    J Pharmacol Exp Ther; 1967 Apr; 156(1):70-5. PubMed ID: 6023602
    [No Abstract]   [Full Text] [Related]  

  • 13. Reserpine rigidity and adrenergic neurones.
    Morrison AB; Webster RA
    Neuropharmacology; 1973 Aug; 12(8):725-33. PubMed ID: 4795744
    [No Abstract]   [Full Text] [Related]  

  • 14. On the role of brain catecholamines in motor activity: experiments with inhibitors of synthesis and of monoamine oxidase.
    Svensson TH; Waldeck B
    Psychopharmacologia; 1970; 18(4):357-65. PubMed ID: 5491473
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiamphetamine effects following inhibition of tyrosine hydroxylase.
    Weissman A; Koe BK; Tenen SS
    J Pharmacol Exp Ther; 1966 Mar; 151(3):339-52. PubMed ID: 5938473
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the functional role of intraneuronal monamine oxidase.
    Clarke DE; Sampath SS
    J Pharmacol Exp Ther; 1973 Dec; 187(3):539-49. PubMed ID: 4770399
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological studies on tetrabenazine-induced excited behaviour of rats pretreated with amphetamine or nialamide.
    Scheel-Krüger J; Jonas W
    Arch Int Pharmacodyn Ther; 1973 Nov; 206(1):47-65. PubMed ID: 4798103
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine oxidase and cerebral uptake of dopaminergic drugs.
    Cotzias GC; Tang LC; Ginos JZ
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2715-9. PubMed ID: 4137067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and accumulation of 3H-noradrenaline in adrenergic nerves of rat iris. Effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Hamberger B; Malmfors T; Sachs C
    Eur J Pharmacol; 1969 Oct; 8(1):58-72. PubMed ID: 5357075
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
    Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.